title: Acquired hemostatic defects during L-asparaginase therapy.
authors.forename: N
authors.initials: N
authors.lastname: Marwaha
authors.forename: R K
authors.initials: RK
authors.lastname: Marwaha
authors.forename: R
authors.initials: R
authors.lastname: Sarode
authors.forename: S
authors.initials: S
authors.lastname: Kaur
authors.forename: K
authors.initials: K
authors.lastname: Ghosh
authors.forename: G
authors.initials: G
authors.lastname: Garewal
authors.forename: D
authors.initials: D
authors.lastname: Mohanty
mesh_terms: D001215:Asparaginase / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000097:blood* / Q000188:drug therapy; D011446:Prospective Studies
chemical_list: D001215:Asparaginase